Press Release Details

Stepan Reports Fourth Quarter and Full Year 2014 Results, Announces Restructuring Charges, and Declares Quarterly Dividend

NORTHFIELD, Ill., Feb. 18, 2015 /PRNewswire/ -- Stepan Company (NYSE: SCL) today reported:

Fourth Quarter Highlights

  • Reported net income was $6.2 million or $0.27 per diluted share versus $10.7 million or $0.46 per diluted share in the prior year quarter.
  • Net sales declined 4% versus the prior year quarter primarily due to a 7% decrease in volume.
  • Restructuring charges recognized in the current year quarter were $3.0 million after-tax.  These charges were attributable to an early retirement incentive program and certain asset write-offs.  The combined annual savings of the 2013 and 2014 restructuring charges are expected to be approximately $3 million per year.
  • Adjusted net income* was $8.8 million or $0.38 per diluted share versus $14.3 million or $0.62 per diluted share in the prior year quarter.

Full Year Highlights

  • Reported net income was $57.1 million or $2.49 per diluted share versus $72.8 million or $3.18 per diluted share in the prior year.
  • Net sales increased 2% versus the prior year primarily due to a 7% increase in selling prices partially offset by a 4% decline in volume.
  • Polymer net sales were up 14% versus the prior year due to strong volume growth in North America and Europe.  The Polymer segment delivered record operating income for the full year.
  • Surfactant net sales declined 2% versus prior year primarily due to severe winter weather experienced in the first part of the year and sales volume challenges within North American consumer products.
  • Adjusted net income* was $57.7 million or $2.52 per diluted share versus $74.8 million or $3.26 per diluted share in the prior year.

Adjusted net income is a non-GAAP measure which excludes Deferred Compensation income/ expense as well as other significant and infrequent/non-recurring items.  See Table II for this non-GAAP reconciliation.

"Consistent with this year's prior quarters, the Company's results were significantly impacted by lower Surfactant income partially offset by Polymer income growth for the quarter and the year," said F. Quinn Stepan, Jr., President and Chief Executive Officer.  "Surfactant results were down on lower commodity consumer product volumes in North America and Brazil.  We are aggressively pursuing asset utilization opportunities in North America and believe volumes in Brazil will be up in 2015.  Functional sales were down slightly as lower agricultural volumes were partially offset by higher oil field sales."

"Our Polymer group delivered record operating income for the year supported by greater energy conservation efforts globally and growing specialty CASE resin and polyol volumes."

"In the quarter we completed several major capital projects and took several other actions, including an early retirement program that should favorably impact 2015."

Financial Summary


Three Months Ended

December 31


Twelve Months Ended

December 31

($ in thousands, except

per share data)

2014

2013

%
Change


2014

2013

%
Change









Net Sales

$ 454,231

$ 474,329

(4)


$1,927,213

$1,880,786

+2









Operating Income

9,004

13,905

(35)


90,694

109,153

(17)









Net Income

6,239

10,650

(41)


57,101

72,828

(22)









Adjusted Net Income *

8,774

14,294

(39)


57,746

74,757

(23)









Earnings per Diluted Share

$0.27

$0.46

(41)


$2.49

$3.18

(22)









Adjusted Earnings per

     Diluted Share

$0.38

$0.62

(39)


$2.52

$3.26

(23)


* See Table II for a reconciliation of non-GAAP Adjusted Net Income and Earnings per Diluted Share.

Summary of Fourth Quarter Adjusted Net Income Items

Adjusted net income excludes non-operational deferred compensation income and/or expense as well as certain other significant and infrequent or non-recurring items.

  • Deferred Compensation:  The current year quarter includes $1.6 million of after-tax income versus $2.9 million of after-tax expense in the prior year.
  • Restructuring and Asset Impairment Expense:  The current year quarter includes $3.0 million of after-tax expense versus $0.7 million of after-tax expense in the prior year.  The current year expense is mostly attributable to an early retirement incentive program and write-offs of assets in non-core areas.  The prior year expense relates to the reduction of commodity Surfactant capacity in Canada. The associated savings of all of these actions are expected to be approximately $3 million annually.
  • Environmental Reserve: The current year quarter includes $1.8 million of after-tax environmental reserve expense associated with the Company's Maywood, New Jersey site.
  • Bad Debt (Income) / Expense: The current quarter includes $0.6 million of after-tax income related to a reduction in the bad debt reserve.

Percentage Change in Net Sales

The decrease in quarterly net sales was primarily due to lower sales volume in the Surfactant segment, mostly in North America and Asia.  Net sales in the quarter were also negatively impacted by foreign translations due to the strengthening of the U.S. dollar.  These decreases were partially offset by higher selling prices mostly associated with higher commodity costs in the Surfactant segment.


Three Months Ended

December 31, 2014

Twelve Months Ended

December 31, 2014

Volume

(7%)

(4%)

Selling Price

6%

7%

Foreign Translation

(3%)

(1%)

   Total

(4%)

2%

Segment Net Sales


Three Months Ended

December 31


Twelve Months Ended

December 31

($ in thousands)

2014

2013

%
Change


2014

2013

%

Change









Net Sales








     Surfactants

$308,681

$327,747

(6)


$1,296,638

$1,317,164

(2)

     Polymers

130,634

128,389

2


550,966

483,361

14

     Specialty Products

14,916

18,193

(18)


79,609

80,261

(1)

          Total Net Sales

$454,231

$474,329

(4)


$1,927,213

$1,880,786

2

Segment Sales Volume

Total Company sales volume decreased 7% in the fourth quarter versus prior year.  Full year sales volume decreased 4% versus prior year.

  • Surfactant sales volume declined 10% for the quarter versus the same period in the prior year.  Most of this decrease was attributable to North America which experienced a 10% volume decline.  North American consumer product volume was down primarily due to lost commodity volumes that were communicated in prior quarters.  Specifically, surfactant use per load of laundry has declined due to customer reformulations and as a result, certain customers who are backward integrated are now able to produce more of their requirements in-house.  Also, continuing the trend of prior quarters, the Company chose not to participate in the biodiesel market due to the poor economics associated with this business.  Agricultural surfactant volume declined as targeted industry year-end inventory builds did not recur.  In contrast, North American oilfield volume, including enhanced oil recovery (EOR), increased versus the prior year quarter.  Volumes sold into the household, industrial, and institutional end markets increased as did those sold through our distributor partners.  Surfactant volumes in Asia were down as opportunistic spot methyl ester sales, primarily biodiesel, did not recur.   
  • Polymer sales volume increased 3% for the quarter versus the same prior year quarter.  North America polyol volume, used in rigid foam insulation, grew 3% versus the prior year quarter and continues to benefit from higher energy efficiency standards.  North America specialty polyol volume, used in Coatings, Adhesives, Sealants and Elastomers (CASE), grew 21% in the current quarter.  Europe volume was up slightly in the current quarter despite the current political and economic uncertainties in the region.
  • Specialty Products sales volume declined 12% versus the same prior year quarter primarily due to lower food and flavoring product volume.

Segment Operating Income


Three Months Ended

December 31


Twelve Months Ended

December 31

(All amounts are pre-tax
and $ are in thousands)

2014

2013

%
Change


2014

2013

%
Change









Operating Income








     Surfactants

$12,086

$20,489

(41)


$60,778

$ 100,201

(39)

     Polymers

13,152

11,172

18


60,690

54,536

11

     Specialty Products

(113)

2,562

(104)


10,487

10,902

(4)

Total segment operating income declined $9.1 million or 27% versus the prior year quarter.  Total segment operating income declined $33.7 million or 20% for the full year.  

  • Surfactant operating income declined $8.4 million or 41% versus the prior year quarter.  North American laundry, biodiesel and agricultural accounted for most of this decline.  Each of these areas experienced lower volume and gross profit margins versus the prior year quarter.  The lower margins were primarily attributable to higher freight, material costs, subpar asset utilization and product liability expense.
  • Polymer operating income increased $2.0 million or 18% versus the prior year quarter.  This was attributable to growth in North American Rigid Polyols and Specialty Polyols.
  • Specialty Products operating income declined $2.7 million or 104% versus the prior year quarter.  This decline is primarily due to lower volume and gross profit margins.  The fourth quarter volume decline was due in large part to fluctuations in customer ordering patterns.  Operating income for the full year declined $0.4 million or 4% versus the prior year.  

Corporate Operating Expenses


Three Months Ended

December 31


Twelve Months Ended

December 31

($ in thousands)

2014

2013

%
Change


2014

2013

%
Change









Total - Corporate
Expenses

$ 15,048

$ 18,202

(17)


$ 37,664

$ 51,509

(27)









Deferred Compensation

Expense/(Income)*

(2,148)

6,003

NM


(11,903)

9,496

NM









Restructuring and Asset Impairments

4,009

1,040

NM


4,009

1,040

NM









Adjusted Corporate
Expense

$ 13,187

$ 11,159

18


$ 45,558

$ 40,973

11









* See Table III for a discussion of deferred compensation plan accounting.

  • For the 4th quarter, Corporate operating expenses, excluding deferred compensation, restructuring and asset impairments, increased $2.0 million or 18% for the quarter.  This increase was mostly attributable to higher environmental remediation reserve expense related to the Company's Maywood, NJ site, higher legal expenses related to future growth opportunities and higher consulting expenses related to our efficiency initiative.  These increases were partially offset by lower incentive-based compensation expense. 
  • For the full year, adjusted corporate operating expenses increased $4.6 million or 11%.  The full year increase was primarily due to a $7.1 million environmental remediation reserve adjustment related to the Company's Maywood, NJ site.  Lower incentive-based compensation expense partially offset this reserve adjustment. 

Income Taxes

The effective tax rates for both full year 2014 and 2013 were 24.4%.

Selected Balance Sheet Information

The Company's net debt level increased $12.2 million for the quarter and $51.4 million for the year.  The increase versus year-end was mostly due to a $48.1 million decline in cash which was primarily attributable to lower earnings, higher working capital requirements and higher property, plant and equipment capital expenditures.


12/31/14

9/30/14

6/30/14

3/31/14

12/31/13

Net Debt






Total Debt

$ 273.9

$ 265.2

$ 271.3

$ 269.6

$ 270.6

Cash

85.2

88.7

96.4

96.7

133.3

Net Debt

$ 188.7

$ 176.5

$ 174.9

$ 172.9

$ 137.3

Equity

536.9

575.8

586.4

564.3

553.7

Net Debt + Equity

$ 725.6

$ 752.3

$ 761.3

$ 737.2

$ 691.0







Net Debt /

(Net Debt + Equity)

26.0%

23.5%

23.0%

23.5%

19.9%

The major working capital components are: 


12/31/14

12/31/13

12/31/12

Net Receivables

$270.5

$265.7

$255.9

Inventories

183.2

172.4

162.0

Accounts Payable

(157.0)

(157.3)

(141.7)


$296.7

$280.8

$276.2

Capital spending for continuing operations was $102 million for the full year versus $93 million in the prior year.

Outlook

"In 2015 Stepan Company is positioned to re-establish earnings momentum," said F. Quinn Stepan, Jr., President and Chief Executive Officer.  "Continued income growth in Polymers, higher functional surfactant volumes, improved operations, recovery of higher freight costs and benefits from falling raw material prices should favorably impact 2015."

"Commodity consumer product and Biodiesel volumes in North America remain a challenge, but opportunities to improve Surfactant asset utilization are being aggressively pursued.  Conversely, consumer product volumes in Brazil should increase in 2015 supported by our planned plant acquisition, now anticipated to close at the end of the first quarter.  Globally, Surfactant volumes sold for functional applications should benefit from a recovery in our agricultural business."

"Polymer income should grow in 2015 from continued energy conservation efforts throughout the world and the introduction of new specialty CASE resins and polyols.  Additional polyol capacity is planned for 2016 in China, Poland and the United States."

"Our internal efficiency program using internal and external resources, is advancing and should deliver meaningful results in 2015 and beyond."

Dividend Declaration

On February 17, 2015, the Board of Directors of Stepan Company declared a quarterly cash dividend on its common stock of $0.18 per share.  The dividend is payable on March 13, 2015, to common stockholders of record on February 27, 2015.  The Company increased its quarterly cash dividend by $0.01 per share in the fourth quarter of 2014, marking the 47th consecutive year of paying increased dividends.

Conference Call

Stepan Company will host a conference call to discuss the fourth quarter and year end results at 10:00 a.m. ET (9:00 a.m. CT) on February 18, 2015. Telephone access to the live conference call will be available by dialing +1 (800) 732-8470.  To listen to a live webcast of this call, please go to our Internet website at: www.stepan.com, click on investor relations, next click on conference calls and follow the directions on the screen.

Corporate Profile

Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries.  Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning compounds.  The Company is also a leading supplier of Polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, Elastomers) industries.

Headquartered in Northfield, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia.

The common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL.  For more information about Stepan Company please visit the Company online at www.stepan.com

Contact: Scott D. Beamer, 847-446-7500

Except for historical information, all other information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied.  The most significant of these uncertainties are described in Stepan Company's Form 10-K, Form 8-K and Form 10-Q reports and exhibits to those reports, and include (but are not limited to), prospects for our foreign operations, foreign currency fluctuations, certain global and regional economic conditions, the probability of future acquisitions and the uncertainties related to the integration of acquired businesses, the probability of new products, the loss of one or more key customer or supplier relationships, the costs and other effects of governmental regulation and legal and administrative proceedings, including the expenditures necessary to address and resolve environmental claims and proceedings, and general economic conditions.  These forward-looking statements are made only as of the date hereof, and Stepan Company undertakes no obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise.

 



Table I


STEPAN COMPANY

For the Three and Twelve Months Ended December 31, 2014 and 2013

(Unaudited – 000's Omitted)














Three Months Ended

December 31


Twelve Months Ended

December 31








2014

2013


2014

2013







Net Sales

$ 454,231

$ 474,329


$ 1,927,213

$ 1,880,786

Cost of Sales

404,380

413,392


1,677,650

1,599,101

   Gross Profit

49,851

60,937


249,563

281,685







Operating Expenses:






   Selling

10,308

12,166


54,763

53,229

   Administrative

16,230

22,446


54,646

71,454

   Research, Development

       and Technical Services

10,300

 

11,380


45,451

 

46,809


36,838

45,992


154,860

171,492







   Business Restructuring and

        Asset Impairments

4,009

1,040


 

4,009

1,040

Operating Income

9,004

13,905


90,694

109,153







Other Income (Expense):






   Interest, Net

(2,617)

(2,863)


(11,441)

(10,358)

   Loss from Equity

   in Joint Venture

 

(1,166)

 

(1,275)


(5,008)

 

(5,336)

   Other, Net

791

543


1,290

2,171


(2,992)

(3,595)


(15,159)

(13,523)







Income Before Income Taxes

6,012

10,310


75,535

95,630

Provision for Income Taxes

(213)

(227)


18,454

23,293

Net Income

6,225

10,537


57,081

72,337







Net Loss  Attributable to the Noncontrolling Interests

14

 

113


20

 

491







Net Income Attributable to

Stepan Company

$     6,239

 

$   10,650


$      57,101

 

$      72,828







Net Income Per Common Share Attributable to Stepan Company






   Basic

$0.27

$0.47


$2.51

$3.22

   Diluted

$0.27

$0.46


$2.49

$3.18







Shares Used to Compute Net

Income Per Common Share
Attributable to Stepan Company






   Basic

22,704

22,753


22,758

22,621

   Diluted

22,830

22,949


22,917

22,924

 

 

Table II


Reconciliation of Non-GAAP Net Income and Earnings Per Diluted Share



Three Months Ended December 31


Twelve Months Ended December 31

($ in thousands,
except per share
amounts)

2014


2013


2014


2013


Net Income

 

EPS


Net Income

 

EPS


Net Income

 

EPS


Net Income

 

EPS

Net Income Reported

$   6,239

$ 0.27


$ 10,650

$ 0.46


$ 57,101

$ 2.49


$ 72,828

$ 3.18













Deferred

Compensation

Expense (Income)

(1,623)

(0.07)


2,921

0.13


(8,288)

(0.36)


3,720

0.16













Restructuring  and Asset Impairment Expense

3,049

0.13


723

0.03


3,049

0.13


723

0.03













Environmental

Remediation

Expense

1,752

0.08



4,403

0.19














Bad Debt Expense (Income)

 

(643)

 

(0.03)


 

 


 

1,481

 

0.07














Business Interruption

Insurance 

Recovery



 

 


(2,514)

(0.11)













Adjusted Net Income

$   8,774

$ 0.38


$ 14,294

$ 0.62


$ 57,746

$ 2.52


$ 74,757

$ 3.26
















All amounts are after tax

The Company believes that certain non-GAAP measures, when presented in conjunction with comparable GAAP (Generally Accepted Accounting Principles) measures, are useful because that information is an appropriate measure for evaluating the Company's operating performance.  Internally, the Company uses this non-GAAP information as an indicator of business performance, and evaluates management's effectiveness with specific reference to these indicators.  These measures should be considered in addition to, neither a substitute for, or superior to, measures of financial performance prepared in accordance with GAAP.

 

Table III



Deferred Compensation Plan


The full effect of the deferred compensation plan on quarterly pretax income was $2.6 million of income versus $4.7 million of expense in the prior year quarter.  The full year impact was $13.4 million of income versus $6.0 million of expense in the prior year.  The accounting for the deferred compensation plan results in operating income when the price of Stepan Company common stock or mutual funds held in the plan fall and expense when they rise.  The Company also recognizes the change in value of mutual funds as investment income or loss.  The quarter end market prices of Stepan Company common stock are as follows:



2014


2013


12/31

9/30

6/30

3/31


12/31

9/30

6/30

3/31

Stepan Company

$40.08

$44.38

$52.86

$64.56


$65.63

$57.73

$55.61

$63.10

 


The deferred compensation expense income statement impact is summarized below:






Three Months Ended

December  31


Twelve Months Ended

December 31

($ in thousands)

2014

2013


2014

2013







Deferred Compensation






   Administrative (Expense)

$ 2,148

$ (6,003)


$ 11,903

$ (9,496)

   Other, net – Mutual Fund Gain

469

1,291


1,464

3,496

       Total Pretax

$ 2,617

$ (4,712)


$ 13,367

$ (6,000)







       Total After Tax

$ 1,623

$ (2,921)


$ 8,288

$ (3,720)

 


Table IV



Effects of Foreign Currency Translation


The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results).  Below is a table that presents the impact that foreign currency translation had on the changes in consolidated net sales and various income line items for the quarter and year ending December 31, 2014:   


($ in millions)

Three Months

Ended December 31

Increase

(Decrease)

(Decrease)
Due to Foreign
Currency
Translation


2014

2013



Net Sales

$ 454.2

$ 474.3

(20.1)

(13.5)

Gross Profit

49.9

60.9

(11.0)

(1.7)

Operating Income

9.0

13.9

(4.9)

(0.9)

Pretax Income

6.0

10.3

(4.3)

(0.9)



($ in millions)

Twelve Months

Ended December 31

Increase

(Decrease)

 (Decrease)

Due to Foreign
Currency
Translation


2014

2013



Net Sales       

$1,927.2

$1,880.8

46.4

(10.8)

Gross Profit

249.6

281.7

(32.1)

(1.9)

Operating Income

90.7

109.2

(18.5)

(1.2)

Pretax Income

75.5

95.6

(20.1)

(1.2)

 

Table V


Stepan Company
Consolidated Balance Sheets
December 31, 2014 and December 31, 2013



2014

December 31

2013

December 31

ASSETS






Current Assets

$575,556

$608,550




Property, Plant & Equipment, Net

524,195

494,042




Other Assets

62,263

64,610




   Total Assets

$1,162,014

$1,167,202







LIABILITIES AND STOCKHOLDERS' EQUITY






Current Liabilities

$249,513

$268,993




Deferred Income Taxes

15,804

20,616




Long-term Debt

246,897

235,246




Other Non-current Liabilities

112,856

88,606




Total Stepan Company Stockholders' Equity

535,546

552,286




Noncontrolling Interest

1,398

1,455




   Total Liabilities and Stockholders' Equity

$1,162,014

$1,167,202

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/stepan-reports-fourth-quarter-and-full-year-2014-results-announces-restructuring-charges-and-declares-quarterly-dividend-300037590.html

SOURCE Stepan Company

This site uses cookies to continuously improve your browsing experience. By clicking on "I Accept," you are agreeing to Stepan Company's use of cookies, our Privacy Policy and Terms & Conditions.